nobel biocare holding ag-reg
Raymund Breu Ph.D.
|Age||Total Calculated Compensation||This person is connected to 13 board members in 1 different organizations across 7 different industries.|
See Board Relationships
Dr. Raymund Breu, Ph.D. served as the Chief Financial Officer of Novartis AG from 1996 to February 1, 2010 and served as its Executive Officer. Dr. Breu was an in charge of all finance activities and strategic planning of the Novartis Group. He served as Chief Financial Officer of Novartis Institutes for BioMedical Research, Inc., Novartis Group and Novartis Consumer Health, Inc. He joined group treasury of Sandoz, a predecessor company of Novartis, in 1975. He was responsible ...
Balz Zimmermann-Strasse 7Phone: 41 43 211 42 00
Kloten, Zurich 8302
Fax: 41 43 211 42 42
Board Members Memberships*
Eidgenössische Technische Hochschule Zürich
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|John C. Martin Ph.D.||Chairman and Chief Executive Officer|
Gilead Sciences Inc.
|Paul Bulcke B.E.||Chief Executive Officer, Member of Executive Board, Director and Member of Chairman's & Corporate Governance Committee|
|Alex Gorsky||Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee|
Johnson & Johnson
|Kenneth C. Frazier||Chairman, Chief Executive Officer and President|
Merck & Co. Inc.
|Olivier Brandicourt||Chief Executive Officer and Director|
|--||Compensation as of Fiscal Year 2014.|